In the News
Dr. Vittorio Gallo joins Seattle Children's as the Chief Scientific Officer. Read more about his achievements and contributions.
Congratulations to Dr. Umoren for receiving an R18 grant for her 4-year study on Pediatric Transport Learning Laboratory (PTLL) and The TELENEO Trial in the field of pediatrics and healthcare research.
The Academic Enrichment Fund Review Committee will conduct a two-year prospective cohort study to explore the quality of life for survivors of CDH.
Using new gene-editing techniques, researchers in Seattle Children’s Research Institute’s Center for Immunity and Immunotherapies (CIIT) have created a novel cell-based therapy with the potential to transform the treatment and/or prevention of Type I diabetes, as well as other autoimmune, allergic and autoinflammatory diseases.
New RSV Vaccine Offering Protection for Infants Approved with the Help of Research from Seattle Children’s.
Dr. Hannibal Person will join the Center for Diversity and Health Equity (CDHE) as the medical director beginning November 2023.
With the start of the school year approaching, adolescent medicine expert Dr. Yolanda Evans says this season of change is a key time for parents to be attuned to changes in their children’s mental health.
“Most people don’t realize that over 80 percent of pediatric cancers are curable,” Dr. Sarah Leary, told The Epoch Times.
Eight cases of locally acquired malaria have been confirmed in Florida and Texas this summer. Dr. Alexis Kaushansky, a malaria expert, weighs in.